IMO Foundation's Partnerships
Building long-term synergies and strengthening partnerships is one of the keys to the IMO Foundation's ability to expand the scope of its work and consolidate its efforts. These are its main international alliances:
COLUMBIA UNIVERSITY OF NEW YORK. Collaboration for the development of stem cells through skin biopsies of patients affected by Retinal Dystrophies.
Recornea, in charge of the development of the prototype in the European clinical research project Human Eye, led by the IMO Foundation.
Blueacre Technology, responsible for the prototype tests in the European clinical research project Human Eye, led by the IMO Foundation.
CHU de Toulouse, university hospital where part of the European clinical research project Human Eye, led by the IMO Foundation, will be carried out.